5 documents found, page 1 of 1
Paediatric familial hypercholesterolaemia screening in Europe: public policy ba...
Gidding, Samuel S.; Wiegman, Albert; Groselj, Urh; Freiberger, Tomas; Peretti, Noel; Dharmayat, Kanika I.; Daccord, Magdalena; Bedlington, NicolaFamilial hypercholesterolaemia (FH) is under-recognized and under-treated in Europe leading to significantly higher risk for premature heart disease in those affected. As treatment beginning early in life is highly effective in preventing heart disease and cost-effective in these patients, screening for FH is crucial. It has therefore now been recognized by the European Commission Public Health Best Practice Po...
Overview of the current status of familial hypercholesterolaemia care in over 6...
EAS Familial Hypercholesterolaemia Studies Collaboration; Vallejo-Vaz, Antonio J.; De Marco, Martina; Stevens, Christophe A.T.; Akram, AsifManagement of familial hypercholesterolaemia (FH) may vary across different settings due to factors related to population characteristics, practice, resources and/or policies. We conducted a survey among the worldwide network of EAS FHSC Lead Investigators to provide an overview of FH status in different countries.
2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein...
Landmesser, Ulf; Chapman, M. John; Stock, Jane K.; Amarenco, Pierre; Belch, Jill J. F.; Borén, Jan; Farnier, Michel; Ference, Brian A.; Gielen, Stephan
New prospects for PCSK9 inhibition?
Landmesser, Ulf; Chapman, M. John; Stock, Jane K.; Amarenco, Pierre; Belch, Jill J. F.; Borén, Jan; Farnier, Michel; Ference, Brian A.; Gielen, Stephan
European Society of Cardiology/European Atherosclerosis Society Task Force cons...
Landmesser, Ulf; Chapman, M. John; Farnier, Michel; Gencer, Baris; Gielen, Stephan; Hovingh, G. Kees; Lüscher, Thomas F.; Sinning, David